ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,464.62
-0.16%
Dow Jones
39,150.33
0.04%
US Dollar vs MXN
18.1108
0.00%
Brent Oil
84.39
0.00%
Bitcoin
64,115.62
-0.20%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Renovaro Inc (RENB)

  7. Renovaro Inc (RENB) Noticias

RENB Renovaro Inc

1.49
0.05 (3.47%)
21 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Renovaro Inc RENB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.05 3.47% 1.49 23:00:06
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.55 1.26 1.60 1.57 1.44
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/6/202417:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202408:06GLOBERenovaro, Inc. Announces $10 million in Equity Committed
11/6/202410:29EDGAR2Form 144 - Report of proposed sale of securities
06/6/202414:52EDGAR2Form 144 - Report of proposed sale of securities
30/5/202420:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202415:33EDGAR2Form 8-K - Current report
24/5/202409:19EDGAR2Form 8-K - Current report
24/5/202408:20GLOBERenovaro Inc. and Amsterdam UMC Cancer Center Poised to..
17/5/202420:37EDGAR2Form SC 13D/A - General statement of acquisition of..
30/4/202410:00GLOBETransforming Cancer Detection: RenovaroCube Introduces..
24/4/202408:00GLOBERenovaroCube to Acquire 100% Ownership of Cyclomics,..
18/4/202407:45GLOBERenovaro Inc. Proudly Announces the Appointment Of Professor..
07/3/202416:00EDGAR2Form 8-K - Current report
05/3/202416:03EDGAR2Form 8-K - Current report
28/2/202414:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/2/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/2/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202408:25GLOBECutting Edge AI Company GEDiCube and Cyclomics sign binding..
14/2/202409:01GLOBEStatement of Renovaro Inc
13/2/202408:46GLOBECutting Edge AI Company GEDiCube and Cyclomics sign binding..
13/2/202408:31GLOBEAI Pioneer GEDi Cube and Biotech Innovator Renovaro..
25/1/202411:45GLOBERenovaro Biosciences Announces Results of Special Meeting of..
16/1/202407:00GLOBEMessage from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark..
11/10/202308:25GLOBEAvram Miller, Co-Founder of Intel Capital, Joins Renovaro..
10/10/202307:00GLOBERenovaro Biosciences Appoints Two Finance Industry Experts..
06/10/202315:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/10/202315:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/10/202315:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04/10/202315:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/10/202311:05GLOBEMessage from Renovaro Biosciences CEO, The Hon. Mark Dybul,..
02/10/202308:28EDGAR2Form 425 - Prospectuses and communications, business..
02/10/202308:26EDGAR2Form 8-K - Current report
02/10/202308:25GLOBEAI Company GEDiCube and Renovaro Biosciences Sign Definitive..
02/10/202306:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
30/9/202302:32BWGEDi Cube und Renovaro Biosciences unterzeichnen endgültige..
29/9/202316:26EDGAR2Form 425 - Prospectuses and communications, business..
29/9/202316:24EDGAR2Form 8-K - Current report
29/9/202316:00EDGAR2Form NT 10-K - Notification of inability to timely file Form..
29/9/202312:36BWGEDi Cube et Renovaro Biosciences signent un accord..
29/9/202308:15GLOBERenovaro Biosciences and AI Health Company GEDi Cube Sign..
12/9/202305:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202308:15GLOBERenovaro BioSciences Welcomes GEDiCube Announcement of New..
21/8/202308:15GLOBERenovaro BioSciences Congratulates GEDi Cube on Appointment..
09/8/202308:05EDGAR2Form 8-K - Current report
09/8/202308:00GLOBEAI Company GEDi Cube and Renovaro Biosciences Announce a..

Su Consulta Reciente

NASDAQ
RENB
Renovaro
UPBT
LRCBTC
LoopringCoin V2
TG
HPD
China Power Internationa...
USOTC
GRCLF
Graincorp (PK)
LSE
15QQ
Bp Cap
TG
85E
Vita Coco Company Inc The
BOV
BDLL4R
BARDELLA PN
USOTC
EHITF
Edinburgh Investment (PK)
TG
A2R7AF
Castellum AB
BIT
NSCIT2236346
European Investment Bank...
KUCN
FSNUSDT
Fusion
KUCN
HIGHETH
Highstreet token
TG
A28Z5W
US Bancorp
EU
CABG
Carrefour Bond Matures 2...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados